Viela Bio teams with Japanese pharma firm, gets $30M payment
Viela Bio Inc. is working with a Japanese pharmaceutical company to look at developing commercializing the Maryland firm's investigational new drug to treat a rare disease of the b…
Viela Bio Inc. is working with a Japanese pharmaceutical company to look at developing commercializing the Maryland firm's investigational new drug to treat a rare disease of the b…